chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hives. A physician reported via a Co representative that a infant received Prevnar, Hib-Titer, DTaP, and IPV, and hepatitis B vaccines on the same date in 4/01 and subsequently developed generalized hives over his body. Follow-up information received from the physician on 09-JUL-2001 indicated that unspecified skin testing was performed on 13-JUN-2001, and the patient was determinedd to be allergic to the pertussis component of the DTaP vaccine.
Twelve hours following the second vaccine I experienced: fever, aches, fatigue, pain at injection site. Those all resolved after 2 days. Approximately 5 days after receiving the second Pfizer vaccine I had the following side effects: constant BURNING pain in my upper lungs with every breath. It kept me up at night with broken sleep. I went to Urgent Care after 2 weeks. They did a chest Xray and EKG. Both tests were negative. They couldn't find a cause.  Four days later I started a 14-day treatment of Prilosec to see if that would help. It has helped a little. The constant burning sensation has changed to the feeling of bread stuck in my throat. That discomfort exists all day and night. I have been sleeping with 3 pillows to be propped up. The discomfort has continued all day and night. I also had no appetite for 5 days and lost 3 lbs. I have read other similar accounts and those don't give me any hope of it ending anytime soon. It has been over 1 month thus far.
About 10 minutes post-vaccination, pt presented with hives around injection side and up the neck. I gave her 25mg of liquid diphenhydramine and had her stay for observation for 30 minutes. The hives were completely gone after 30 minutes.
The swollen lymph nodes carried over from dose 1 but was exaggerated with more intense and extreme pain. The nodes were more enlarged and was super painful. I reached out to my PCP who advised I get an MRI done of my glands but haven't had it done yet because I read it was a common side effect of the vaccine, and they resolved after about 2 months after receiving the vaccine and have not had any issues since. In July I developed sever dry mouth and that is still ongoing. I saw an ENT with a follow up appointment scheduled in another week to do bloodwork to try to find a cause.
Pt in previously good health received J&J vaccine 04/09 and felt well until 04/21 when she developed lower extremity weakness and incoordination which became progressively worse and was accompanied by slurred speech on the afternoon of 04/22.  The pt's husband helped her into bed and she apparently died during the night of 04/22-04/23.
Pt. stated that area was reddened hot & swollen for 4 days after shot given.  Hadn't had a flu shot in over 7 years.
On vacation in, just got to hotel and fell asleep. Wife said I lifted my head with a strange look on my face, laid back down. Then one minute later had a grand mal seizure. Called 911 and was sent to ER via Ambulance. ER conducted EKG, CAT Scan and other tests to determine the root cause. Found, no tumors or other explanations for the seizure. No prior history of neurological problems. Interestingly both of my parents are also now suffering neurolgical side effects after taking the Pfizer Covid vaccine.
Very bad headache, nausea, pain at injection site. (third pregnancy, due August 12th) Headache started at 3 am the next day, nausea started later that day, have been nauseous for five days, headache lasted three days.
I noticed a very mild headache and slight coldness within 2 hours of my vaccine.  Onset of my severe symptoms began around 10PM on 03/12/2021 with a stabbing headache (Felt like someone took an air pump and kept 'blowing up' my head. My eyes felt achy and heavy and every time I looked in a different direction I would get a zapping/electric feeling throughout my head that would cause my head and neck to spasm (longer duration) or twitch (quick jolt). This also caused dizziness). I got really cold and had intense shivering and shaking. Around midnight, my skin started feeling bruised all over my body (very sensitive to touch, including my bed sheets against my spine felt like rubbing up against a wound). At the same time, my joints (especially my neck, hips, and knees) got hot to the touch and were incredibly painful (induced tears). My muscles developed a deep ache that also caused significant pain. I felt very weak and confused. I didn't take my temperature until the early morning, and it was 102.9 at that time. I alternated taking Tylenol and Ibuprofen throughout the day, but my temperature stayed between 102 and 103.1 for about 24 hours, as did the previously noted symptoms.   I noticed a gradual improvement of my symptoms over the next two days. On the evening of 03/14/2021, my headache worsened some, and I had an unexpected episode where I nearly passed out (dropped to the floor but stayed conscious). I also had intermittent foot tingling (very noticeable, not mild) over the course of a few hours.   For 3 full days (but by far the most severe within the first 24 hours), I experienced some strange sound processing. Things like the sound of a car driving by or the ceiling fan felt like it echoed throughout my whole body and gave me an uncomfortable shivering feeling.   As of today (03/16/2021), I am mostly recovered. I am still experiencing fatigue, a very mild headache, and some mild pain. My nausea has completely resolved, though that was never a chief complaint of mine.   I realize that some of my symptoms are to be expected with this vaccine. But especially the level of pain I experienced throughout my entire body was very concerning and not something that I was aware could happen as a result of the vaccine.
Within 30 minutes post vax, the pt developed an injection site reaction characterized by redness and pain. The pt stated that the vaccine was injected into the side of the arm rather than the deltoid.
Tenderness at injection site early morning 2/20/2021.  Feeling a little tired.  Felt warm so I took my temperature around 12:30 PM today and it is reading 101.0
Itching and burning 30 minutes after injection.  Later in day noted redness and hardness (size of golf ball) at injection site.  This was relieved around 3pm, was told to put ice to area and take Benadryl.  Went to bed early that night due to feeling tired.  Woke up next morning with swelling in neck, chest and numb feeling at base of skull.  Went to see doctor, prescribed prednisone, darvocet, and claritin, continues to have tingling in hand, soreness in neck.  Still has residual side effects.
Loss of taste, smell, brain fog. Am not currently being treated. Side effects began the next day after my 2nd dose on March 1st.
pt recv vax; approx 2 hr later, had high pitched screaming for 4 hr; became limp on all 4 extremities,lasting 16 hr;seen 24 hr p/ vax;head control,good muscle tone;reflexes nl;alert,awake,rest of exam unremarkable;no rashes/swelling;
Itchiness in groin and armpit, leading to increased itchiness accompanied by raised and cluster of hives at groin area
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Oct2021 as dose 3 (booster), single (Lot number: 3203080) at the age of 34 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing); "Migraine" (unspecified if ongoing); "depression" (unspecified if ongoing); "overweight" (unspecified if ongoing). Concomitant medication(s) included: EFFEXOR, start date: 01Sep2019. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Patient received other medication in 2 weeks. Patient received Paxlovid from 23Jun2022 to 27Jun2022 for treatment of COVID-19. Adverse event 4 days after completion of 5 day Paxlovid course, patient experienced a positive rapid test, 101.2 fever, cough, congestion, runny nose, and fatigue all over again (experienced this from 22Jun-24Jun as well when patient was initially positive for COVID 19).; Sender's Comments: Drug ineffective depends on many factors including pharmacokinetics, severity of disease and patient general health condition. However on conservative basis, the possible causality cannot be excluded
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of MMR II (administration route, lot number and expiration date were not provided). No concomitant therapies were reported. No adverse effects were reported. This is one of two reports from the same reporter. Additional information is not expected, since there is no consent to contact the physician to follow up.
booster dose; booster dose; right calf pain; bilateral PE / SOB; This is a spontaneous reporter from a contactable physician. A 71-year-old female patient received BNT162B2 (COMIRNATY) dose 3 on unknown date (reported as 3 weeks ago) at booster dose for COVID-19 immunisation. The patient medical history included prior massive pulmonary embolism (PE) in 1996 associated with hysterectomy (treated with AC for 6-12 months and then off anticoagulation since), chronic lower extremities (LE) edema and venous stasis. The patient concomitant medications included influenza vaccine (Flu shot) in Oct2021 (reported as 2 weeks ago) at unspecified dosage for Immunization. The patient previously received 2 doses of the BNT162B2 (COVID-19 vaccine) for COVID-19 immunisation without incident. The patient experienced short of breath (SOB) and right calf pain on 18Oct2021. The patient was seen in her physicians office on 19Oct2021. Pulmonary CT angiogram on 19Oct2021 revealed bilateral PE and she was started on anticoagulation. Patient and physician questioned if the PE could have been due to the BNT162B2 booster shot. Otherwise, the patient was in good health (except for prior remote postoperative PE) and not on any other medications. The outcome of event was unknown.     The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Based on available information and the drug temporal relationship, the causality between the events - pulmonary embolism, off label use, immunisation and the suspect drug "BNT162B2" cannot be completely excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
shortness of breath/ after talking or walking up the stairs; This is a spontaneous report from a non-contactable consumer (patient).   A female patient of an unspecified age received BNT162B2 (PFIZER COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization.  The patient medical history and concomitant medications were not reported. On an unspecified date, 48 hours after receiving the first dose of the vaccine, the patient experienced shortness of breath that lasted a few hours and then the next day she had shortness of breath, which was not significant. The event happened sometimes after talking or walking up the stairs. She also stated she did not experienced any arm soreness at all. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
7 days after I got the shot, my arm swelled up where the shot was given, was very sore and it itched.  Lasted about 3 days.
Enlarged and tender lymph node in the axilla: The left axilla has no erythema, no rashes, but is notable for a tender, visible well circumscribed 3.5 x 4 cm sub q nodule - most c/w enlarged lymph node.  started 2 days after the second dose of covid vaccine.  no therapy, we are just monitoring
After receiving injection Pt developed immediate aching and pain at site. Pt has experienced aching at site extending down arm.  Pt reports limitation in motion, problem on going. Pt being sent to PMD for evaluation and work-up.
This spontaneous report as received from a medical assistant concerning multiple unspecified patients. On an unknown date the patients were vaccinated with multiple doses of improperly stored ROTATEQ  lot # M006111, expiration date 08-NOV-2017 and M026315 (also reported as N026315) expiration date 26-JAN-2018 for prophylaxis. The temperature was 32°F to 35°F for 72 hours. No adverse events and no product quality complaint were reported. This is one of several reports from the same source.; Sender's Comments: US-009507513-1706USA010023: US-009507513-1707USA000693: US-009507513-1707USA000691:
It was sore at the injection site, like both other shots,; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Mar2021 (Lot number: EN6206) at the age of 54 years as dose 2, single and administered in arm left, administration date 22Feb2021 (Lot number: EN6200) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Dupuytrens" (unspecified if ongoing), notes: Other medical history: Dupuytrens; seasonal allergies (hayfever); "seasonal allergies (hayfever)" (unspecified if ongoing), notes: Other medical history: Dupuytrens; seasonal allergies (hayfever); "seasonal allergies (hayfever)" (unspecified if ongoing), notes: Other medical history: Dupuytrens; seasonal allergies (hayfever). Concomitant medication(s) included: NATURE MADE VITAMIN D3; PROTANDIM; PB8 PROBIOTIC. Past drug history included: Amoxicillin, reaction(s): "Known allergies: Amoxicillin", notes: Known allergies: Amoxicillin. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "It was sore at the injection site, like both other shots."  Additional information: If treatment AE: No, If covid prior vaccination: No, If covid tested post vaccination: No, If other vaccine in four weeks: No, Adverse event: "The third dose hurt a lot more than either, which surprised me. It was sore at the injection site, like both other shots, but this time it's been hot to the touch and a rash has developed about 3 inches below the injection. The site is still very warm to the touch and itchy."  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101803494 similar report from same reporter
Information has been received from a lawyer concerning a report of a professor's "worker" who was vaccinated with a dose of Recombivax HB. Subsequently, the worker became ill after vaccination. There was no further information at the time of this report. Additional information is not expected.
Larger itchy red spot below hte infection site; Larger itchy red spot below hte infection site; Red spot on arm looked like a giant hive; Condition aggravated; Like having a RA flare; Flu-like reaction; Nausea; Fever of 101 for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATOID ARTHRITIS (Like having a RA flare) and ANGIOEDEMA (Red spot on arm looked like a giant hive) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rheumatoid arthritis and Osteoarthritis. Concomitant products included VALSARTAN and AMLODIPINE for Blood pressure management, MELOXICAM for Pain, METHOTREXATE for Rheumatoid arthritis, RITUXIMAB (RITUXAN), METOPROLOL and FOLIC ACID for an unknown indication.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced RHEUMATOID ARTHRITIS (Like having a RA flare) (seriousness criterion medically significant), INFLUENZA LIKE ILLNESS (Flu-like reaction) and PYREXIA (Fever of 101 for 24 hours). 21-Mar-2021, the patient experienced CONDITION AGGRAVATED (Condition aggravated) and NAUSEA (Nausea). On 25-Mar-2021, the patient experienced ANGIOEDEMA (Red spot on arm looked like a giant hive) (seriousness criterion medically significant), ERYTHEMA (Larger itchy red spot below hte infection site) and PRURITUS (Larger itchy red spot below hte infection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 22-Mar-2021, PYREXIA (Fever of 101 for 24 hours) had resolved. On 26-Mar-2021, INFLUENZA LIKE ILLNESS (Flu-like reaction) had resolved. On 27-Mar-2021, RHEUMATOID ARTHRITIS (Like having a RA flare), CONDITION AGGRAVATED (Condition aggravated) and NAUSEA (Nausea) had resolved. On 11-Apr-2021, ANGIOEDEMA (Red spot on arm looked like a giant hive), ERYTHEMA (Larger itchy red spot below hte infection site) and PRURITUS (Larger itchy red spot below hte infection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative (Negative) Negative SARS COVID-2 IG antibody..         Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-169506 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information received on 25-May-2021 contains no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
As the immunization was being given, the solution ran out from the needle hub down the arm. The recipient received less than half the dose as the needle apparently was not tightly connected to the syringe. This was explained to the patient. They agreed to receive a full dose of COVID 19-Moderna immediately following this occurrence so that adequate protection would be obtained.
Initial report received on 04 December 2009 from a consumer.  A female patient (age not provided) with no known allergies began vomiting, had a fever, muscle pain, and weakness eight hours after she received a first time intramuscular dose of ADACEL (lot number unknown) in August 2009.  The patient believed the manufacturer was Sanofi Pasteur.  The patient recovered from the events.  No further information was provided.  List of Documents held by Sender: none.
We had a temperature excursion the previous day that wasn't caught before giving the vaccine. The patient was given HPV and MCV4, as well, but those vaccines were okayed by our coordinator for use. The patient tolerated the vaccines and hadn't reported any reaction. The patient will have to repeat the polio dose.
Severe swelling and pain at site of injection. Swelling enlarged daily for 3 days until it was the size of a grapefruit. Then it started to dissipate and finally went back to normal after 9 days.  Also pain to the touch for the 3 days but then it reduced. After 7 days it was still a little itchy.
This case was reported by a physician and described the occurrence of adverse reaction in a unspecified number of patients who received ENGERIX B adult. On 15th March 2017, the patients received ENGERIX B adult. On an unknown date, less than a year after receiving ENGERIX B adult, the patients experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to ENGERIX B adult. Additional details were provided as follows: It was reported that all the patients who were vaccinated on 15th March 2017, were called with adverse event. This case has been linked with case US2017040276, reported by the same reporter.
07/15/2022   He woke up at 3:30 in the morning with a fever of 104.3. I gave him some Ibuprofen. His temperature stayed between 102 and 104 throughout the day. I called his doctor around 11:00 am. He told me to keep the fever under control. He had no other symptoms.  He had 2 home COVID tests which were both positive.   The fever continued through until the next morning but broke that morning. He stayed tired, not wanting to go outside and was not being himself.  This morning while taking a bath, we noticed the skin is peeling on his toes and the ball of both feet. It almost looks like a blister on one of the toes.  I called the doctor and have not heard back.
Fully vaccinated for COVID-19, tested positive on 1/19/2022, hospitalized 1/26/2022 and died on 1/26/2022 from COVID-19
This spontaneous report as received from a Registered Nurse refers to unspecified pediatric patients of unknown age. On 13-OCT-2014, patients was vaccinated with improperly stored VARIVAX (Merck) (lot# reported as K003423, expiration date not reported, dose, route not reported). No adverse effects reported. Additional information is not expected.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Jan2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 25 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: COVID 19 Treatment with Paxlovid, Treatment start date: 21May2023, Treatment stop date: 25May2023. No Other medication in 2weeks.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.